Summary
For Year 2026-27, Invicta Diagnostic reports the following shareholding: Total Promoters at 66.7%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 4.2%, Domestic Institutional Investors at 4.3%, and Retail at 24.81%. This breakdown provides a quick snapshot of ownership distribution for Invicta Diagnostic in 2026-27.
Invicta Diagnostic FAQs
As of 04-2026, the promoter shareholding in Invicta Diagnostic stands at 66.7% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Invicta Diagnostic is 4.2% and 4.3% respectively.
The retail shareholding of the Invicta Diagnostic is 24.81%.
Changes in shareholding patterns of Invicta Diagnostic can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Invicta Diagnostic are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
